JMP Securities Sticks to Their Hold Rating for Apyx Medical (APYX)
In a report released today, David Turkaly from JMP Securities reiterated a Hold rating on Apyx Medical (APYX – Research Report). The company’s ...
JMP Securities Keeps Their Buy Rating on Braze (BRZE)
JMP Securities analyst Patrick Walravens maintained a Buy rating on Braze (BRZE – Research Report) today and set a price target of $68.00. The ...
JMP raises Kratos stock target to $40 on growth drivers
According to JMP Securities, Kratos Defense & Security is well-positioned to benefit ... particularly in the Government ...